Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 3/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | FYN | P06241 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL4909754 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL10944981 | 1.00 | FFAR3 (0.54) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL19209974 | 1.00 | — | — | |
| Acetic Acid SCHEMBL30992289 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL7880095 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL8676850 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL1025735 | 0.96 | — | — | |
| Acetic Acid SCHEMBL10766537 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL9350314 | 0.96 | FFAR3 (0.58) | FFAR3LCKFYNALDH1A1TDP1 | |
| Acetic Acid SCHEMBL8064727 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118267308-A | Hair waving agent composition suitable for steam waving and application method thereof | 滁州学院 | 2024-07-02 | — | — | CN | claimed |
| US-20060156445-A1 | Molecular motor power-supplying device | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2006-07-13 | — | — | US | claimed |
| US-5120531-A | Rinse-off hair conditioner containing polymer and nonaqueous s solvent | THE PROCTER & GAMBLE COMPANY (US) | 1992-06-09 | — | — | US | claimed |
| WO-1991015186-A1 | HAIR STYLING CONDITIONERS | THE PROCTER & GAMBLE COMPANY (US) | 1991-10-17 | — | — | WO | claimed |
| US-12024533-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240210827-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING CURED RELIEF PATTERN, AND SEMICONDUCTOR APPARATUS | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-06-27 | — | — | US | disclosed |
| US-12006338-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| US-20240101628-A1 | Cancer Treatment | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2024-03-28 | — | — | US | disclosed |
| US-11820792-B2 | Cancer treatment | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-11-21 | — | — | US | disclosed |
| WO-2023215521-A2 | HALIDE-FREE AMMONIUM SILANES | TOPIKOS SCIENTIFIC, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | Tipikos Pharmaceuticals, Inc. (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230265452-A1 | Phagemid Vector | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-08-24 | — | — | US | disclosed |
| EP-0528527-B1 | Conjugates | ZENECA LTD (GB) | 1998-04-08 | — | — | EP | disclosed |
| EP-0663072-B1 | PROCESS FOR ELIMINATING LABILE GLYCOHAEMOGLOBIN FROM A SAMPLE | DREW SCIENT LTD (GB) | 1997-03-05 | — | — | EP | disclosed |
| EP-0663072-A1 | PROCESS FOR ELIMINATING LABILE GLYCOHAEMOGLOBIN FROM A SAMPLE. | DREW SCIENT LTD (GB) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994008242-A1 | PROCESS FOR ELIMINATING LABILE GLYCOHAEMOGLOBIN FROM A SAMPLE | DREW SCIENTIFIC LTD. (GB) | 1994-04-14 | — | — | WO | disclosed |
| EP-0528527-A2 | Conjugates | ZENECA LIMITED (GB) | 1993-02-24 | — | — | EP | disclosed |
| EP-0502637-A2 | Vector | ZENECA LIMITED (GB) | 1992-09-09 | — | — | EP | disclosed |
| US-4582883-A | CURABLE TO CHEMICAL, HEAT RESISTANT THERMOSETTING RESIN | DSM RESINS B.V. (NL) | 1986-04-15 | — | — | US | disclosed |
| US-3972991-A | MEASUREMENT OF FOLATE IN A BLOOD SERUM | CASE WESTERN RESERVE UNIVERSITY (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024533-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | FFAR3 4086/4885LCK 2631/4885FYN 4135/4885 |
| US-12006338-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | FFAR3 4086/4885LCK 2631/4885FYN 4135/4885 |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | FFAR3 4086/4885LCK 2631/4885FYN 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.